Krsnaa Diagnostics Ltd is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The firm has an extensive network of diagnostic centres across India with a key focus on non-metro, and lower tier cities and towns. As of December 31, 2020, it operates 1,801 diagnostic centres that are offering radiology and pathology services across 13 different cities in India. In fiscal 2020, the business has served 5.27 million patients. Rajendra Mutha is the promoter of the company.

For year/ period ended ( in Cr.)

• The Company has large dealer network with 2,000+ registered dealers.
• Strong PAN India presence in 27 states of India.
• International presence with export to 13+ countries across the globe.
• One of the largest manufacturing plants of glazed vitrified tiles in India.

• To make repayment or prepayment of secured borrowings availed by the company.
• To meet working capital requirements.
• Meet general corporate purposes.

The company is in the highly competitive field having fragmented players. Based on super earnings of FY21, the issue is valued at a P/E of 35 plus. Being IPO under Rs. 250 cr., the Company will list in T2T (Trade to Trade) category this may restrict speculative moves.